Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-11-050006)

Filing Details

Accession Number:: 0001181431-11-050006
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-09-20 17:34:37
Reporting Period:: 2011-09-19

Filing Date:: 2011-09-20
Accepted Time:: 2011-09-20 17:34:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178711	Transcept Pharmaceuticals Inc	TSPT	Pharmaceutical Preparations (2834)	330960223

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1210529	A Glenn Oclassen	C/O Transcept Pharmaceuticals, Inc. 1003 W. Cutting Blvd, Suite 110 Point Richmond CA 94804	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-09-19	10,000	$5.80	310,800	No	4	P	Direct
Common Stock	Acquisiton	2011-09-19	10,000	$5.80	73,457	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	See Footnote

Footnotes

Shares held directly by the Reporting Person's spouse.